164 related articles for article (PubMed ID: 34277819)
1. The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.
Lei J; Liu X; Liu W; Zhang Y; Liu Z
Ann Transl Med; 2021 Jun; 9(12):1019. PubMed ID: 34277819
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance.
Zhang L; Xu H; Ma C; Zhang J; Zhao Y; Yang X; Wang S; Li D
J Cancer; 2020; 11(10):2962-2971. PubMed ID: 32226511
[TBL] [Abstract][Full Text] [Related]
3. MiR-4782-3p inhibited non-small cell lung cancer growth via USP14.
Wu N; Zhang C; Bai C; Han YP; Li Q
Cell Physiol Biochem; 2014; 33(2):457-67. PubMed ID: 24556800
[TBL] [Abstract][Full Text] [Related]
4. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitylation and stabilization of Acf7 by ubiquitin carboxylterminal hydrolase 14 (USP14) is critical for NSCLC migration.
Yan G; Liu NA; Wang J; Tian J; Liu H; Li S; Liu W; Li X; Li K; Wang H
J Biosci; 2021; 46():. PubMed ID: 33737492
[TBL] [Abstract][Full Text] [Related]
6. Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases.
Moon S; Muniyappan S; Lee SB; Lee BH
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207520
[TBL] [Abstract][Full Text] [Related]
7. A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37.
van der Wal L; Bezstarosti K; Demmers JAA
J Proteomics; 2022 Jun; 262():104592. PubMed ID: 35489684
[TBL] [Abstract][Full Text] [Related]
8. Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4.
Jia C; Zhang X; Qu T; Wu X; Li Y; Zhao Y; Sun L; Wang Q
PeerJ; 2023; 11():e14654. PubMed ID: 36632137
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
Yu F; Liu JB; Wu ZJ; Xie WT; Zhong XJ; Hou LK; Wu W; Lu HM; Jiang XH; Jiang JJ; Cao ZY; Cong GJ; Shi MX; Jia CY; Lu GX; Song YC; Chai L; Lv ZW; Wu CY; Ma YS; Fu D
Cancer Lett; 2018 Jul; 427():74-84. PubMed ID: 29702194
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression.
Bustamante HA; Albornoz N; Morselli E; Soza A; Burgos PV
Cell Signal; 2023 Jan; 101():110490. PubMed ID: 36241058
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin.
Wu N; Liu C; Bai C; Han YP; Cho WC; Li Q
Int J Mol Sci; 2013 May; 14(6):10749-60. PubMed ID: 23702845
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
Zhao Z; Xu H; Wei Y; Sun L; Song Y
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166594. PubMed ID: 36328147
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase PSMD14 promotes tumorigenicity of glioblastoma by deubiquitinating and stabilizing β-catenin.
Wang Y; Liu Y; Ma C; Liu C; Tang Q; Wang Z; Lu J; Chen Z; Wang H
Biofactors; 2024 May; ():. PubMed ID: 38696072
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
Sun T; Liu Z; Bi F; Yang Q
Mol Oncol; 2021 Dec; 15(12):3639-3658. PubMed ID: 34382324
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma.
Zhang B; Li M; Huang P; Guan XY; Zhu YH
Thorac Cancer; 2017 Jul; 8(4):344-349. PubMed ID: 28509417
[TBL] [Abstract][Full Text] [Related]
18. Hes-related family BHLH transcription factor with YRPW motif 1-activated proteasome 26S subunit, non-ATPase 14 regulates trophoblast function and endometrial angiogenesis.
Zhang L; Zhang S; Chen F
Exp Ther Med; 2022 Jul; 24(1):476. PubMed ID: 35761814
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with
Ma YS; Wang XF; Zhang YJ; Luo P; Long HD; Li L; Yang HQ; Xie RT; Jia CY; Lu GX; Chang ZY; Zhang JJ; Xue SB; Lv ZW; Yu F; Xia Q; Fu D
Mol Ther Oncolytics; 2020 Mar; 16():147-157. PubMed ID: 32055678
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
